Clinical outcomes in patients receiving edoxaban or phenprocoumon for prevention of stroke in atrial fibrillation: a German real-world cohort study

Clinical outcomes in patients receiving edoxaban or phenprocoumon for prevention of stroke in atrial fibrillation: a German real-world cohort study

Abstract Background Appropriate and timely anticoagulant therapy with vitamin K antagonists (VKAs) or non-vitamin K oral antagonists (NOACs) is essential for stroke prevention in non-valvular atrial fibrillation (NVAF). Comparative data regarding effectiveness and safety for edoxaban vs phenprocoumo...

Full description

Bibliographic Details
Main Authors: Christopher Hohmann, Magnus Lutz, Sheila Vignali, Kathrin Borchert, Karolin Seidel, Sebastian Braun, Stephan Baldus, Michael Näbauer
Format: Article
Language:English
Published: BMC 2022-07-01
Series:Thrombosis Journal
Subjects:
VKA
Edoxaban
Atrial fibrillation
Stroke
Claims data
Online Access:https://doi.org/10.1186/s12959-022-00395-x

Internet

https://doi.org/10.1186/s12959-022-00395-x

Similar Items